Abstract
The objectives of this study were to evaluate the therapy protocol of gamma globulin (GG) re-treatment without steroids. Patients. From Jun. 1994 to Jun. 2001, 220 typical patients were enrolled within 8 days of illness. They had no coronary artery dilatation at admission and before GG treatment. Their risks were evaluated by the Iwasa's risk score system. Of 220 patients, 66% were selected as high-risk patients and 80% were treated with GG. Initial dose of GG was single 2g/kg for the high-risk patients and 1g/kg for the low-risk patients with prolonged fever, 49 patients had GG re-treatment. Maximum dose of GG was 8g/kg and mean dose of GG was 1.8g/kg per patient. Dose of re-treatment after Sep. 1996 was decided by WBC and CRP before and after GG treatment. Results. Of 220 patients, 13 patients had coronary artery lesions (CAL, over 3 mm in diameter) in acute stage and 3 patients had CAL at 30th days of illness, which were all transient dilatation. In high-risk female patients, 51 patients treated with GG had no CAL. In high-risk male patients from Jun. 1994 to Jun. 1999, 60 patients were treated with sulfonated GG (Sulfo-GG) or GG prepared by propylene glycol (PEG-GG). And CAL (8/31) in Sulfo-GG group was significantly higher than CAL (1/29) in PEG-GG group (p=0.017). In high-risk male patients after Jul. 1999, when we did not use Sulfo-GG, 1/22 had CAL. The other 3 CAL patients, whose CAL were under 3.1 mm in diameter, were high-risk patient without GG, low -risk patient without GG and high-risk patient with GG. Persistent fever over 10 days of illness occurred in 20/159 patients before Jun. 1999, but 3/61 after Jul. 1999. Duration of fever after Jul. 1999 was significantly shorter than that before Jun. 1999 (p = 0.039). Repetition of PEG-GG treatment can reduce CAL.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwasa, M., Fukuta, K., Yokoyama, T. et al. Gamma Globulin Therapy in Kawasaki Disease. Pediatr Res 53, 180 (2003). https://doi.org/10.1203/00006450-200301000-00157
Issue Date:
DOI: https://doi.org/10.1203/00006450-200301000-00157